RxDoctor Payments DataLook up a doctor →

Stephanie Vanderveldt, MD

Ophthalmology · Atlanta, GANPI 1538109160

Payments from drug & device makers

$384,462in general payments, 2019–2025

Across 337 payments — averaging $1140.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • US Retina LLC$271K
  • Genentech USA, Inc.$69K
  • Alimera Sciences, Inc.$16K
  • Novartis$10K
  • AbbVie$5K
  • Apellis Pharmaceuticals, Inc.$4K
  • plus $9K from 16 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$384,462 in reported general payments places this provider in the 95th percentile of 481 ophthalmology providers in Georgia.

See all ophthalmology providers in Georgia

Medicare billing

Part B allowed, 2024
$5,861,393
Medicare patients
1,512
Services billed
119,371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →